Latest stories

  • in

    SII in talks on fill finishing Oxford University R21 malaria vaccine in Ghana: Expert

    Bengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University‘s R21 malaria vaccine in Ghana, which approved the shot this month, a Ghanaian vaccine expert said on Thursday. Fill-finishing is one of the final stages of drug manufacturing and packaging. The vaccine’s approval by Ghana and Nigeria was unusual because final-stage […] More

  • in

    University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana

    University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana

    London: The R21/Matrix-M malaria vaccine, developed by the University of Oxford, leveraging an adjuvant technology from Novavax, and manufactured and scaled up by the Serum Institute of India Pvt Ltd (SIIPL), has been granted full national licensure for use in Ghana by the country’s Food and Drugs Authority (FDA Ghana). This marks the first regulatory […] More